Peptide Elongation Factor 2 [elongační faktor 2]
topical
4
- Terms
-
cytoplazmatický elongační faktor 2
EF-2
peptidy - elongační faktor 2
-
Cytoplasmic Elongation Factor 2
EF-2
Elongation Factor 2
NSP 100
NSP100
Persistent link
https://www.medvik.cz/link/D020652
Definition
Peptide Elongation Factor 2 catalyzes the translocation of peptidyl-tRNA from the A site to the P site of eukaryotic ribosomes by a process linked to the hydrolysis of GTP to GDP.
- DUI
- D020652 MeSH Browser
- CUI
- M0328223
- Previous indexing
- Peptide Elongation Factors (1980-1999)
- History note
- 2000; for ELONGATION FACTOR 2 use PEPTIDE ELONGATION FACTOR 2 (NM) 1980-1999
- Public note
- 2000; ELONGATION FACTOR 2 was indexed under PEPTIDE ELONGATION FACTORS 1980-1999
Allowable subheadings
- AD
- administration & dosage
- AE
- adverse effects
- AG
- agonists
- AN
- analysis
- AI
- antagonists & inhibitors
- BI
- biosynthesis
- BL
- blood
- CF
- cerebrospinal fluid
- CS
- chemical synthesis
- CH
- chemistry
- CL
- classification 1
- DF
- deficiency
- DE
- drug effects
- EC
- economics
- GE
- genetics 4
- HI
- history
- IM
- immunology
- IP
- isolation & purification
- ME
- metabolism
- PK
- pharmacokinetics
- PD
- pharmacology
- PH
- physiology
- PO
- poisoning
- RE
- radiation effects
- ST
- standards
- SD
- supply & distribution
- TU
- therapeutic use
- TO
- toxicity
- UL
- ultrastructure
- UR
- urine
...
Occurrences in Medvik records
D
Chemicals and Drugs
D08.811.277.040.330.300.100
GTP Phosphohydrolase-Linked Elongation Factors
D12.776.157.325.150
GTP Phosphohydrolase-Linked Elongation Factors
D12.776.476.338.100
GTP Phosphohydrolase-Linked Elongation Factors
D12.776.835.700.350
GTP Phosphohydrolase-Linked Elongation Factors